Global Circulating Tumor Cells Market Size, Status and Forecast 2020-2026
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
USA is the largest supplier of CTCs Products, with a revenue market share nearly 47.41% in 2017. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 26.24% in 2017. Asia has the highest growth rate. Vendors recognize the importance of this region, particularly in China, India and are working towards penetrating this market by strengthening their sales and distribution networks.
Market Analysis and Insights: Global Circulating Tumor Cells Market
In 2019, the global Circulating Tumor Cells market size was US$ 1078.5 million and it is expected to reach US$ 4009.1 million by the end of 2026, with a CAGR of 20.4% during 2021-2026.
Global Circulating Tumor Cells Scope and Market Size
Circulating Tumor Cells market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Circulating Tumor Cells market is segmented into CTC Enrichment, CTC Detection, CTC Analysis, etc.
Segment by Application, the Circulating Tumor Cells market is segmented into Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Other, etc.
Regional and Country-level Analysis
The Circulating Tumor Cells market is analysed and market size information is provided by regions (countries).
The key regions covered in the Circulating Tumor Cells market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Circulating Tumor Cells market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Circulating Tumor Cells business, the date to enter into the Circulating Tumor Cells market, Circulating Tumor Cells product introduction, recent developments, etc.
The major vendors include Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech, Fluxion Biosciences, Ikonisys, Hangzhou Watson Biotech, Biocept, CytoTrack, Guangzhou Wondfo Biotech, Celsee, Clearbridge Biomedics, ANGLE plc, etc.
This report focuses on the global Circulating Tumor Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cells development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc
CTC Enrichment
CTC Detection
CTC Analysis
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Other
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Circulating Tumor Cells status, future forecast, growth opportunity, key market and key players.
To present the Circulating Tumor Cells development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Circulating Tumor Cells are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
USA is the largest supplier of CTCs Products, with a revenue market share nearly 47.41% in 2017. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 26.24% in 2017. Asia has the highest growth rate. Vendors recognize the importance of this region, particularly in China, India and are working towards penetrating this market by strengthening their sales and distribution networks.
Market Analysis and Insights: Global Circulating Tumor Cells Market
In 2019, the global Circulating Tumor Cells market size was US$ 1078.5 million and it is expected to reach US$ 4009.1 million by the end of 2026, with a CAGR of 20.4% during 2021-2026.
Global Circulating Tumor Cells Scope and Market Size
Circulating Tumor Cells market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Circulating Tumor Cells market is segmented into CTC Enrichment, CTC Detection, CTC Analysis, etc.
Segment by Application, the Circulating Tumor Cells market is segmented into Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Other, etc.
Regional and Country-level Analysis
The Circulating Tumor Cells market is analysed and market size information is provided by regions (countries).
The key regions covered in the Circulating Tumor Cells market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Circulating Tumor Cells Market Share AnalysisCirculating Tumor Cells market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Circulating Tumor Cells business, the date to enter into the Circulating Tumor Cells market, Circulating Tumor Cells product introduction, recent developments, etc.
The major vendors include Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech, Fluxion Biosciences, Ikonisys, Hangzhou Watson Biotech, Biocept, CytoTrack, Guangzhou Wondfo Biotech, Celsee, Clearbridge Biomedics, ANGLE plc, etc.
This report focuses on the global Circulating Tumor Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cells development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc
Market segment by Type, the product can be split into
CTC Enrichment
CTC Detection
CTC Analysis
Market segment by Application, split into
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Circulating Tumor Cells status, future forecast, growth opportunity, key market and key players.
To present the Circulating Tumor Cells development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Circulating Tumor Cells are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
